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tution. Cost (not charges) of the index hospitalization
included direct and indirect costs and was normalized to
2010 values. Data are mean /- S.D.
Results: 306 patients underwent either CEA (n174)
or CAS (n132). Patients undergoing CEA trended to-
wards a higher prevalence of being symptomatic (44.8
%)compared to CAS(34.0%,P 0.09). Age was not signif-
icantly different between patients undergoing CEA and
CAS (70.2 vs 72.0,respectively, P0.36). CAD was more
common in patients undergoing CAS (60.3% vs
39%,P0.003). The prevalence of COPD, ESRD, Hyper-
tension and diabetes were not significantly significant.
Mean hospital cost for CAS was $9426/5776 while
CEA cost was $6734/3935 (P  0.0001). This cost
differential was driven by the higher direct supply costs for
CAS ($5634) vs CEA ($1967),(P  .0001). These
higher costs for CAS were seen consistently in symptom-
atic, asymptomatic, elective and urgent subgroups (Table).
30 day stroke/death/MI rate was 2.3%(4/174)in the CEA
group and 3.8%(5/132) in the CAS group,P0.5. Overall
LOS was 2.1 days in both groups (P0.9).
N
Length of
Stay (days) Cost ($) P
CAS CEA CAS CEA CAS CEA
Entire Cohort 132 174 2.1 2.06 9426 6734 0.0001
Symptomatic 45 78 3.5 2.85 12128 7750 0.0001
Asymptomatic 87 96 1.3 1.43 7983 5835 0.0068
Elective 118 152 1.4 1.34 8538 5841 0.0001
Urgent 14 22 7.5 7.05 16095 12540 0.0542
Conclusions: Treatment of carotid artery disease with
CAS was 40% more costly than CEA and did not provide
better clinical outcomes or a reduction in LOS. The cost
differential was driven entirely by the increased supply costs
in the CAS cohort. At present, carotid stenting cannot be
considered a cost-effective treatment for carotid artery
disease.
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Objectives: To analyze early and long term results of
endovascular infrainguinal peripheral revascularizations in
female patients in a single centre experience.
Methods: From January 2000 to March 2010, 223
consecutive endovascular interventions for femoro-popli-
teal disease in 214 patients were performed. Interventions
were performed in females in 71 cases (group 1) and in
males in 152 cases (group 2).
Early and follow-up results were analyzed and com-
pared with appropriate statistical tests.
Results: There were no differences between the two
groups in terms of risk factors for atherosclerosis, comor-
bidities, clinical status, TASC II classification of arterial
lesions and technical characteristics of the procedures.
Technical failure rate was 3.9% in group 2, while no
failure occurred in group 1 (p0.09).
Cumulative 30-day mortality was 0.9%, with no differ-
ence between females (no deaths) and males (2 deaths,
1.3%; p0.3). Overall amputation rate at 30 days was 1.3%,
again with no differences between the two groups (2.8%
and 0.7%, respectively; p0.2); also the rate of periopera-
tive thrombosis (overall 2.7%) was similar between the two
groups (2.8% and 2.6%, respectively; p0.4).
Follow-up was available in 95 % of patients with a mean
duration of 17 months (range 1-85).
Estimated 36-month survival rates were 95% in group 1
and 81.8% in group 2 (p0.3; log-rank 0.9). Primary,
assisted primary and secondary patency rates at 36 months
were 39.8%, 49.1% and 62% in group 1 and 41.3%, 55.5%
and 75% in group 2, without significant differences be-
tween the two groups. Also the rates of freedom from any
(open or endovascular) reintervention and from conversion
to surgical bypass at 3 years were similar. In patients with
critical limb ischemia, limb salvage rates at 36 months were
80.5% and 90.3, respectively (p0.7, log-rank 0.2).
Conclusions: Endovascular treatment of femoro-pop-
liteal occlusive disease provides similar results between
males and females at an intermediate follow-up.
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Objectives: Cardiac risk factors encompassed in the
Revised Cardiac Risk (RCR) index help identify patients at
the highest cardiac risk in the surgical population. Recently,
high-sensitivity C-reactive protein (hs-CRP), the common
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